Table 2.
Baseline characteristics of participants and mortality from CVD, non-CVD, and all causes according to FPG and 2-h plasma glucose categories
| Men |
Women |
|||
|---|---|---|---|---|
| Group I: 2-h PG ≤ FPG | Group II: 2-h PG > FPG | Group I: 2-h PG ≤ FPG | Group II: 2-h PG > FPG | |
| n (%) | 6,663 (53.0) | 5,903 (47.0) | 4,096 (37.7) | 6,778 (62.3) |
| Age (years) | 52 (52–53)† | 55 (55–55) | 52 (52–53)† | 54 (54–54) |
| BMI (kg/m2) | 25.5 (25.4–25.6)† | 25.9 (25.8–26.0) | 25.4 (25.3–25.6)† | 26.0 (25.9–26.1) |
| FPG (mmol/l) | 5.3 (5.3–5.3) | 5.2 (5.2–5.2) | 5.2 (5.2–5.3) | 5.2 (5.2–5.2) |
| 2-h PG (mmol/l) | 4.3 (4.3–4.4)† | 6.2 (6.2–6.3) | 4.5 (4.5–4.5)† | 6.3 (6.3–6.3) |
| Fasting insulin (pmol/l)* | −0.03 (−0.06 to 0)† | 0.08 (0.05–0.11) | −0.11 (−0.14 to −0.08)† | 0.04 (0.01–0.07) |
| Total cholesterol (mmol/l) | 6.2 (6.2–6.3) | 6.2 (6.2–6.2) | 6.2 (6.2–6.3) | 6.3 (6.2–6.3) |
| Blood pressure (mmHg) | ||||
| Systolic | 131 (130–131) | 133 (133–134) | 128 (128–129) | 132 (132–133) |
| Diastolic | 81 (81–82) | 83 (83–83) | 78 (77–78) | 80 (80–80) |
| Current smoking (%) | 23.4† | 20.2 | 23.9† | 17.9 |
| Hypertension (%) | 35.6† | 47.1 | 34.3† | 45.2 |
| Mortality per 1,000 person years (n) | ||||
| CVD | 5.4 (378)† | 7.4 (449) | 1.4 (59)† | 2.3 (187) |
| Non-CVD | 4.3 (299) | 5.1 (312) | 2.8 (122) | 2.9 (229) |
| All-cause | 9.7 (677)† | 12.5 (761) | 4.2 (181)† | 5.2 (416) |
Data are n (%) or age- and study-adjusted means (95% CIs).
*9,978 men and 7,350 women with z score transformation.
†P < 0.001 for different between groups in men and women.